← All companies

MDNA

Medicenna Therapeutics Corp.

MDNAF OTC Pharmaceutical Preparations EDGAR ↗

$0.25

+0.01 +2.83%

Key statistics

from XBRL data in SEC filings

Market cap

$17.7M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.23 – $1.43

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K May 13, 2024 6-K FORM 6-K Apr 30, 2024 6-K FORM 6-K Apr 26, 2024 6-K FORM 6-K Apr 25, 2024 6-K FORM 6-K Apr 10, 2024 6-K FORM 6-K Apr 9, 2024 6-K FORM 6-K Apr 4, 2024 6-K FORM 6-K Mar 6, 2024 6-K FORM 6-K Feb 14, 2024 6-K FORM 6-K Feb 13, 2024 6-K FORM 6-K Jan 24, 2024 6-K FORM 6-K Jan 16, 2024 6-K FORM 6-K Jan 9, 2024 6-K FORM 6-K Jan 5, 2024 6-K FORM 6-K Dec 22, 2023 6-K FORM 6-K Dec 22, 2023 6-K FORM 6-K Nov 21, 2023 6-K FORM 6-K Nov 14, 2023 6-K FORM 6-K Nov 8, 2023 6-K FORM 6-K Oct 25, 2023 6-K FORM 6-K Oct 24, 2023 6-K FORM 6-K Oct 10, 2023 6-K FORM 6-K Oct 3, 2023 6-K FORM 6-K Sep 28, 2023 6-K FORM 6-K Sep 28, 2023 6-K FORM 6-K Sep 6, 2023 6-K FORM 6-K Aug 28, 2023 6-K FORM 6-K Aug 28, 2023 6-K FORM 6-K Aug 14, 2023 6-K FORM 6-K Aug 9, 2023 6-K FORM 6-K Aug 8, 2023 6-K FORM 6-K Aug 4, 2023 6-K FORM 6-K Aug 1, 2023 6-K FORM 6-K Jul 28, 2023 6-K FORM 6-K Jul 25, 2023 6-K FORM 6-K Jul 6, 2023 6-K FORM 6-K Jun 27, 2023 20-F FORM 20-F Jun 27, 2023 6-K FORM 6-K Apr 27, 2023 6-K FORM 6-K Apr 18, 2023